VEEV 📈 Veeva Systems Class A - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9224751084
VEEV: Cloud-Based, Software, Analytics, CRM, Content, Management, Solutions
Veeva Systems Inc. is a cloud-based software provider that caters specifically to the life sciences industry, offering a range of solutions that enable pharmaceutical and biotechnology companies to streamline their operations and improve customer engagement. The company's product portfolio includes Veeva Commercial Cloud, a suite of software and analytics solutions that comprise Veeva customer relationship management (CRM), which allows customer-facing employees to manage their interactions more effectively. Additionally, Veeva Vault PromoMats provides an end-to-end content and digital asset management solution, while Veeva Vault Medical serves as a source of medical content across multiple channels and geographies.
The company's analytics capabilities are further enhanced by Veeva Crossix, a platform designed for pharmaceutical brands to gain valuable insights, and Veeva OpenData, a customer reference data solution that facilitates more accurate and informed decision-making. Moreover, Veeva Link enables the generation of real-time intelligence, and Veeva Compass provides access to de-identified and longitudinal patient data for the United States, offering a more comprehensive understanding of patient trends and behaviors. These solutions collectively empower life sciences companies to optimize their commercial operations, drive business growth, and improve patient outcomes.
Veeva Systems Inc. also provides Veeva Development Cloud, a suite of applications tailored to support the clinical, regulatory, quality, and safety functions within life sciences organizations. This includes Veeva Vault Clinical, Veeva Vault RIM, Veeva Vault Safety, and Veeva Vault Quality, which collectively facilitate the management of clinical trials, regulatory submissions, and quality control processes. Furthermore, the company offers Veeva QualityOne, a quality and document management, and training solution, as well as Veeva RegulatoryOne, which simplifies the management of regulatory submission content. Veeva Claims is another key solution, addressing the end-to-end product and marketing claims management process to ensure compliance and accuracy.
In addition to its software solutions, Veeva Systems Inc. provides a range of professional and support services designed to help life sciences companies implement and optimize their use of Veeva's products. These services include implementation and deployment planning, project management, requirements analysis, solution design, and configuration, as well as systems environment management and deployment services. The company also offers services focused on advancing or transforming business and operating processes related to Veeva solutions, data migration and systems integrations technical consulting services, training on its solutions, and ongoing managed services, such as outsourced systems administration. With its comprehensive suite of software solutions and support services, Veeva Systems Inc. is well-positioned to meet the evolving needs of the life sciences industry.
Headquartered in Pleasanton, California, Veeva Systems Inc. was incorporated in 2007 and has since established itself as a leading provider of cloud-based software solutions for the life sciences industry. The company's website can be found at https://www.veeva.com, and its common stock is listed on the NYSE under the ticker symbol VEEV, with the ISIN code US9224751084 and classified under the GICS Sub Industry of Health Care Technology.
Additional Sources for VEEV Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
VEEV Stock Overview
Market Cap in USD | 36,897m |
Sector | Healthcare |
Industry | Health Information Services |
GiC Sub-Industry | Health Care Technology |
IPO / Inception | 2013-10-16 |
VEEV Stock Ratings
Growth 5y | 12.5% |
Fundamental | 68.0% |
Dividend | - |
Rel. Strength Industry | 748 |
Analysts | 3.93/5 |
Fair Price Momentum | 204.08 USD |
Fair Price DCF | 149.98 USD |
VEEV Dividends
No Dividends PaidVEEV Growth Ratios
Growth Correlation 3m | 77.1% |
Growth Correlation 12m | 17.9% |
Growth Correlation 5y | -25.1% |
CAGR 5y | 9.37% |
CAGR/Mean DD 5y | 0.33 |
Sharpe Ratio 12m | 0.53 |
Alpha | -9.84 |
Beta | 1.06 |
Volatility | 34.89% |
Current Volume | 2374.3k |
Average Volume 20d | 1481.6k |
As of December 22, 2024, the stock is trading at USD 224.15 with a total of 2,374,290 shares traded.
Over the past week, the price has changed by -5.51%, over one month by +4.66%, over three months by +2.46% and over the past year by +19.78%.
Yes, based on ValueRay Fundamental Analyses, Veeva Systems Class A (NYSE:VEEV) is currently (December 2024) a good stock to buy. It has a ValueRay Fundamental Rating of 68.02 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VEEV as of December 2024 is 204.08. This means that VEEV is currently overvalued and has a potential downside of -8.95%.
Veeva Systems Class A has received a consensus analysts rating of 3.93. Therefor, it is recommend to buy VEEV.
- Strong Buy: 10
- Buy: 9
- Hold: 9
- Sell: 0
- Strong Sell: 1
According to ValueRays Forecast Model, VEEV Veeva Systems Class A will be worth about 227.4 in December 2025. The stock is currently trading at 224.15. This means that the stock has a potential upside of +1.43%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 248.6 | 10.9% |
Analysts Target Price | 226.3 | 0.9% |
ValueRay Target Price | 227.4 | 1.4% |